Single nucleotide replacement in the Atlantic salmon genome using CRISPR/Cas9 and asymmetrical oligonucleotide donors.
Aquaculture
Gene editing
HDR
Knock-in
New breeding technologies
ODN
Journal
BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258
Informations de publication
Date de publication:
22 Jul 2021
22 Jul 2021
Historique:
received:
23
03
2021
accepted:
17
06
2021
entrez:
23
7
2021
pubmed:
24
7
2021
medline:
27
7
2021
Statut:
epublish
Résumé
New breeding technologies (NBT) using CRISPR/Cas9-induced homology directed repair (HDR) has the potential to expedite genetic improvement in aquaculture. The long generation time in Atlantic salmon makes breeding an unattractive solution to obtain homozygous mutants and improving the rates of perfect HDR in founder (F0) fish is thus required. Genome editing can represent small DNA changes down to single nucleotide replacements (SNR). This enables edits such as premature stop codons or single amino acid changes and may be used to obtain fish with traits favorable to aquaculture, e.g. disease resistance. A method for SNR has not yet been demonstrated in salmon. Using CRISPR/Cas9 and asymmetrical ODNs, we were able to perform precise SNR and introduce a premature stop codon in dnd in F0 salmon. Deep sequencing demonstrated up to 59.2% efficiency in single embryos. In addition, using the same asymmetrical ODN design, we inserted a FLAG element into slc45a2 and dnd, showing high individual perfect HDR efficiencies (up to 36.7 and 32.7%, respectively). In this work, we demonstrate that precise SNR and knock-in (KI) can be performed in F0 salmon embryos using asymmetrical oligonucleotide (ODN) donors. We suggest that HDR-induced SNR can be applied as a powerful NBT, allowing efficient introgression of favorable alleles and bypassing challenges associated with traditional selective breeding.
Sections du résumé
BACKGROUND
BACKGROUND
New breeding technologies (NBT) using CRISPR/Cas9-induced homology directed repair (HDR) has the potential to expedite genetic improvement in aquaculture. The long generation time in Atlantic salmon makes breeding an unattractive solution to obtain homozygous mutants and improving the rates of perfect HDR in founder (F0) fish is thus required. Genome editing can represent small DNA changes down to single nucleotide replacements (SNR). This enables edits such as premature stop codons or single amino acid changes and may be used to obtain fish with traits favorable to aquaculture, e.g. disease resistance. A method for SNR has not yet been demonstrated in salmon.
RESULTS
RESULTS
Using CRISPR/Cas9 and asymmetrical ODNs, we were able to perform precise SNR and introduce a premature stop codon in dnd in F0 salmon. Deep sequencing demonstrated up to 59.2% efficiency in single embryos. In addition, using the same asymmetrical ODN design, we inserted a FLAG element into slc45a2 and dnd, showing high individual perfect HDR efficiencies (up to 36.7 and 32.7%, respectively).
CONCLUSIONS
CONCLUSIONS
In this work, we demonstrate that precise SNR and knock-in (KI) can be performed in F0 salmon embryos using asymmetrical oligonucleotide (ODN) donors. We suggest that HDR-induced SNR can be applied as a powerful NBT, allowing efficient introgression of favorable alleles and bypassing challenges associated with traditional selective breeding.
Identifiants
pubmed: 34294050
doi: 10.1186/s12864-021-07823-8
pii: 10.1186/s12864-021-07823-8
pmc: PMC8296724
doi:
Substances chimiques
Nucleotides
0
Oligonucleotides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
563Informations de copyright
© 2021. The Author(s).
Références
Sci Rep. 2016 Mar 15;6:22953
pubmed: 26976234
Dis Model Mech. 2018 Oct 18;11(10):
pubmed: 30355591
Sci Rep. 2018 Oct 30;8(1):16054
pubmed: 30375441
Elife. 2020 May 15;9:
pubmed: 32412410
Gen Comp Endocrinol. 2016 Jun 1;232:191-8
pubmed: 26764212
Mol Ther Methods Clin Dev. 2019 Nov 27;17:156-173
pubmed: 31909088
Animals (Basel). 2019 Apr 17;9(4):
pubmed: 30999629
Trends Genet. 2019 Sep;35(9):672-684
pubmed: 31331664
Sci Rep. 2020 Dec 17;10(1):22271
pubmed: 33335280
Sci Rep. 2017 Aug 4;7(1):7301
pubmed: 28779173
Sci Rep. 2019 May 17;9(1):7533
pubmed: 31101849
Transgenic Res. 2019 Aug;28(Suppl 2):101-105
pubmed: 31321691
Sci Rep. 2018 Nov 7;8(1):16499
pubmed: 30405210
Sci Rep. 2016 Feb 18;6:21284
pubmed: 26888627
Front Genet. 2018 Apr 06;9:117
pubmed: 29681919
Sci Rep. 2017 Mar 07;7:43733
pubmed: 28266557
Nucleic Acids Res. 2016 Sep 6;44(15):e128
pubmed: 27257074
Sci Rep. 2020 Jan 15;10(1):409
pubmed: 31941961
Genetics. 2014 Jun;197(2):591-9
pubmed: 24709635
Biol Reprod. 2014 Dec;91(6):136
pubmed: 25320148
Sci Rep. 2020 Oct 22;10(1):18042
pubmed: 33093479
PLoS Genet. 2015 Nov 09;11(11):e1005628
pubmed: 26551894
Dev Biol. 2017 Aug 1;428(1):63-73
pubmed: 28527702
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10745-E10754
pubmed: 29183983
G3 (Bethesda). 2019 Jan 9;9(1):287-295
pubmed: 30482801
PLoS One. 2014 Sep 25;9(9):e108622
pubmed: 25254960
Endocrinology. 2016 Jun;157(6):2500-14
pubmed: 27046435
PLoS Genet. 2015 Nov 20;11(11):e1005678
pubmed: 26588702
Sci Rep. 2015 May 15;5:10131
pubmed: 25976364
Nat Biotechnol. 2016 Mar;34(3):339-44
pubmed: 26789497